OMER wins FDA approval for YARTEMLEA, the first TA-TMA therapy, marking its first commercial product and a shift to revenue generation.

An informational consumer evaluation guide to best blood sugar supplement criteria for 2026, Akkermansia muciniphila and ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

The latest update is out from Can-Fite BioPharma ( (CANF) ).

A healthy gut may be far more important for women’s bone health than previously believed. New research conducted by AIIMS has ...

Cafe Casino strengthens its presence in the No Deposit Casino Canada market by introducing structured online casino bonuses ...

Here, BioSpace looks back at the biggest acquisition deals of 2025. Target: Intra-Cellular Therapies Acquisition date: ...

An evidence-based exploration of how culinary botanicals synergize with cannabinoids to create pharmacologically active, ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Adult acne appears after the age of 25 Various factors are behind this Can stress cause adult acne too Our expert answers ...

Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...